Sanjivani Paranteral Ltd
BSE:531569
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Sanjivani Paranteral Ltd
Selling, General & Administrative
Sanjivani Paranteral Ltd
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sanjivani Paranteral Ltd
BSE:531569
|
Selling, General & Administrative
-₹64.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Selling, General & Administrative
-₹59.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-6%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Selling, General & Administrative
-₹51.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Selling, General & Administrative
-₹109.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-9%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Selling, General & Administrative
-₹43.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Selling, General & Administrative
-₹24.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-11%
|
|
Sanjivani Paranteral Ltd
Glance View
Sanjivani Paranteral Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, anti-spasmodic, multivitamin, nutrition, iron, NSAID and analgesic, analgesic anti spasmodic, analgesic, and NSAID. Its antibiotic includes Netilmicin Sulphate, Amikacin Sulphate, and Gentamycin Sulphate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic includes Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamin include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, Diazepam, and Dobutamine Hydrochloride. Its Iron includes iron Sucrose. Its analgesic includes Metamizole.
See Also
What is Sanjivani Paranteral Ltd's Selling, General & Administrative?
Selling, General & Administrative
-64.9m
INR
Based on the financial report for Mar 31, 2025, Sanjivani Paranteral Ltd's Selling, General & Administrative amounts to -64.9m INR.
What is Sanjivani Paranteral Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-20%
Over the last year, the Selling, General & Administrative growth was -58%. The average annual Selling, General & Administrative growth rates for Sanjivani Paranteral Ltd have been -28% over the past three years , -20% over the past five years .
